Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Evogene Stock Price, Quotes and Forecasts | NASDAQ:EVGN | Benzinga

Q: What sector and industry does Evogene (EVGN) operate in?

Evogene is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Evogene stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EVGN.

Open	$1.42
Close	-
Volume / Avg.	28.32K / 44.49K
Day Range	$1.31 - $1.51
52 Wk Range	1.20 - 10.40
Market Cap	$7.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.3%
Days to Cover	1

Recent News

Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'

Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported $5.6 million in total revenue for the year. CEO Ofer Haviv highlighted the company's successful collaborations with industry leaders like Corteva, ICL, and Syngenta, contributing to revenue growth. In Q4, gross profit decreased to $180,000, but net financing income rose to $287,000. Total operating expenses increased to $7.8 million, leading to a net loss of $7.3 million. For the full year, gross profit reached $3.9 million, and net financing income was approximately $521,000. Evogene also secured partnerships with Verb Biotics and Colors Farm, along with receiving a €1.2 million EU grant for its Ag-Seed Division's research and development efforts.

Jelena Martinovic

Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges

Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech.

Patricio Liddle

Why Evogene Shares Are Moving

Evogene Ltd (NASDAQ: EVGN) shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indicating that the company is not in compliance with the minimum bid price rule.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.42
Close	-
Volume / Avg.	28.32K / 44.49K
Day Range	$1.31 - $1.51
52 Wk Range	1.20 - 10.40
Market Cap	$7.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	0.3%
Days to Cover	1

About

Sector

Healthcare

Industry

N/A

Evogene Ltd is a computational biology company targeting to revolutionize product development for li...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Evogene (EVGN) stock?

You can purchase shares of Evogene (NASDAQ:EVGN) through any online brokerage.

View our list of the best stock brokerages

Who are Evogene (EVGN) competitors?

There are no as such competitors for Evogene.

What is the forecast, or price target, for Evogene (EVGN) stock?

Evogene has a consensus price target of $6.96.

What is the current price for Evogene (EVGN)?

The stock price for Evogene (NASDAQ: EVGN) is $1.41 last updated March 3, 2025 at 3:58 PM EST.

Does Evogene (EVGN) pay a dividend?

There are no upcoming dividends for Evogene.

When is Evogene (NASDAQ:EVGN) reporting earnings?

Evogene’s Q1 earnings are confirmed for Thursday, May 22, 2025.

Is Evogene (EVGN) going to split?

There is no upcoming split for Evogene.

What sector and industry does Evogene (EVGN) operate in?

Evogene is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Evogene Stock Price, Quotes and Forecasts

Evogene (EVGN) Forecast